Enough talk, time to act!

Enough talk, time to act!

During this week’s Inspire2Live World Campus session—where we come together to learn, share, and act—our guest speaker was Dr Wilbert Bannenberg from the Pharmaceutical Accountability Foundation (PAF). Dr Bannenberg has spent decades fighting to bring essential...
The true test of medical added value

The true test of medical added value

This week in the Netherlands, several medicines were removed from reimbursement – specifically, PARP inhibitors. We won’t delve into Dutch specifics, but this leads us to ask: When is a medicine of added value, and what criteria should we consider? We were immediately...
Prevention needs a business model

Prevention needs a business model

On June 10 and 11, Inspire2Live attended the Economist Impact 10th annual World Cancer Series Europe congress: ‘Shaping the cancer-control agenda’. One engaging session explored a crucial question: What should be the priority for the near and distant future? The...